Psoriasis — Topical and Systemic Treatment Refills Treatment
Covered by Aetna in California

Mild-moderate plaque psoriasis: triamcinolone 0.1% cream BID to affected areas (Tier 1, avoid face/intertriginous); calcipotriene 0.005% cream or solution once or twice daily (vitamin D analog — steroid-sparing, effective for scalp and non-facial plaque; combine with betamethasone dipropionate for enhanced effect); clobetasol propionate 0.05% (high-potency — limit to 2-week continuous use, then pulse dosing to prevent skin atrophy). Moderate-severe plaque or when topicals fail: methotrexate 10–25mg weekly PO or SQ (Tier 1; folic acid 1mg daily required; LFT monitoring quarterly initially)

Apremilast (Otezla) 30mg twice daily for moderate-severe (PA required, step through topicals; oral, no immunosuppression, useful for patients who cannot use biologics or prefer injectable-free; PASI 75 in ~33% at 16 weeks); secukinumab (Cosentyx) 300mg SQ monthly after 5-week loading (IL-17A inhibitor — preferred biologic for scalp, nail, and joint involvement; Aetna preferred specialty drug for psoriasis; PASI 90 in ~60% at 12 weeks per pivotal trials); risankizumab (Skyrizi) 150mg SQ Q12 weeks (IL-23 inhibitor, highest durability data — preferred biologic on Aetna step therapy list, PASI 90 in 72% at 52 weeks); adalimumab biosimilars (Hadlima, Amjevita, multiple options — TNF inhibitor, step therapy preferred starting agents on some Aetna CA plans)

Tier 1 topicals covered without PA. Apremilast requires PA + topical step therapy. Biologics require PA + specialty step therapy through preferred agents; if approved, specialty copay (typically $100–$300/month depending on plan tier and manufacturer copay assistance). Manufacturer copay cards for Cosentyx, Skyrizi, Tremfya significantly reduce out-of-pocket to $0–$25/month for commercially insured patients. Methotrexate is Tier 1 generic (~$10–$20/month).

AAD-NPF Joint Biologics Guideline supports biologics as first-line systemic option for moderate-to-severe plaque psoriasis (PASI >10, BSA >10%, or significant quality-of-life impact). IL-17 and IL-23 inhibitors achieve the highest PASI 90/100 response rates. Prior to biologic initiation: TB screening (QuantiFERON or PPD), hepatitis B surface antigen, hepatitis C antibody, CBC, CMP — Dr. Bhavsar orders these labs and reviews results before submitting PA. Telehealth appropriate for topical management, ongoing biologic refills (stable patients), and pre-PA documentation. In-person dermatology needed for: biologic injection training (first dose typically administered in-office), liver biopsy candidacy for methotrexate, or complex presentations (pustular, erythrodermic, PsA joint evaluation). Psoriasis patients have elevated cardiovascular risk — ASCVD screening is appropriate at each visit.

Yes, for new biologic starts. Aetna CA's specialty preferred step therapy list requires new psoriasis biologic patients to first try preferred agents. As of 2024, the Aetna preferred biologics for psoriasis include: adalimumab biosimilars (Amjevita, Hadlima, etc.), Cosentyx (secukinumab), Enbrel (etanercept), and Skyrizi (risankizumab). Non-preferred biologics (including some newer agents) require documented inadequate response to at least one preferred agent. If Dr. Bhavsar is documenting your prior biologic history to support a PA for a specific agent, the visit summary will include response data, adverse events, and medical necessity rationale. Patients continuing an existing biologic (already on treatment) are typically approved for continuation without new step therapy.

Yes. Mild psoriasis (BSA <5% or DLQI <10, without nail, scalp, genital, or joint involvement) is well-managed with prescription topicals via telehealth. Dr. Bhavsar will prescribe a regimen tailored to your distribution and skin sensitivity: typically a mid-to-high potency steroid (triamcinolone or betamethasone valerate) alternated with calcipotriene to minimize steroid atrophy, with clobetasol for breakthrough flares. Specialty areas (face, groin, skin folds) get gentler options — desonide 0.05% or tacrolimus ointment 0.1% (off-label). All of these are Tier 1 generics on Aetna CA, requiring no prior authorization.

TDMD can complete the clinical documentation required for a biologic PA — disease severity, prior treatment history, failed topical and systemic therapies, pre-biologic lab results (TB, hepatitis B/C, CBC, CMP), and medical necessity rationale. Dr. Bhavsar will review your lab results and photo documentation to write a comprehensive PA letter. However, some Aetna CA plans specifically require the PA to be submitted by a dermatologist or rheumatologist for biologic initiation. In those cases, TDMD prepares the documentation package for a dermatology referral, which significantly reduces the time and complexity of your in-person specialist visit.

Yes. Aetna commercial plans cover telehealth visits for Psoriasis — Topical and Systemic Treatment Refills in California. TeleDirectMD (Dr. Parth Bhavsar, MD, NPI: 1104323203) is an in-network telehealth provider with Aetna in California. Your standard Aetna telehealth copay applies — typically $10–$40 for most commercial plans. If clinically appropriate, your prescription is sent to your California pharmacy immediately after your visit.

Most Aetna commercial plans in California have telehealth copays of $10–$40. Often $0–$20 for employer plans. Your exact cost depends on your specific plan and whether your deductible has been met. Log into your Aetna member portal or call the member services number on your card to verify your telehealth copay before your psoriasis treatment refills visit. Self-pay is always available for a flat $49 if you prefer to skip insurance.

If your specific Aetna plan is not in-network with TeleDirectMD in California, or if your deductible has not yet been met, you can book as a self-pay patient for a flat $49 fee — same physician, same quality of care, no insurance needed. You may also be eligible to submit an out-of-network claim to Aetna for partial reimbursement depending on your plan's out-of-network benefit.

TeleDirectMD typically offers same-day and next-day video visits. Book at teledirectmd.com/book-online and select a time that works for you. Most patients are seen within a few hours of booking during business hours. Your psoriasis treatment refills symptoms are evaluated by Dr. Bhavsar, MD — not a nurse practitioner or PA — ensuring you receive a board-certified clinical assessment.

Yes. TeleDirectMD is operated by Dr. Parth Bhavsar, MD (NPI: 1104323203), a board-certified Family Medicine physician. TeleDirectMD is LegitScript certified, HIPAA compliant, and is contracted as an in-network telehealth provider with Aetna in California. Claims are billed using standard CPT codes (99213/99214) and submitted electronically to Aetna.

Yes. Telehealth visits with a licensed physician are qualified medical expenses eligible for FSA (Flexible Spending Account) and HSA (Health Savings Account) payment. If your Aetna plan applies your deductible first, your FSA or HSA card can be used to pay your portion. The $49 self-pay option is also FSA/HSA eligible.